Strains

Conviction comes from verifying the Strain Number.

Strain Number HY8002

The information provided is general academic and patent-related content concerning the raw material and does not describe the efficacy or effects of any specific product.Strain Numbers are assigned by hy in accordance with internal Strain management and naming standards, following the identification of Strain characteristics through in-house research.
Strain Information
TypeNotified probiotics
Functional
Properties
May help promote the growth of beneficial bacteria, inhibit harmful bacteria, support regular bowel movements, and contribute to gut health
SpeciesBifidobacterium animalis subsp. lactis
StrainHY8002
OriginHuman body
Certifications-
Distinct Characteristics of the Strain
Strain Number HY8002
The notified probiotic Strain Number HY8002
is a beneficial microorganism that may help promote the growth of beneficial bacteria, inhibit harmful bacteria, support regular bowel movements, and contribute to gut health.
The notified probiotic Strain Number HY8002
is a beneficial microorganism that may help promote the growth of beneficial bacteria, inhibit harmful bacteria, support regular bowel movements, and contribute to gut health.
At hy Research Center, Strain Numbers are assigned in accordance with internal management standards, and continuous research is conducted on the various efficacies and characteristics of each Strain.At hy Research Center, Strain Numbers are assigned
in accordance with internal management standards, and continuous research is conducted on the various efficacies and characteristics of each Strain.
Research on the Strain
The hy Research Center is conducting research on the functional properties of Strain Number HY8002.Understanding Strain-specific capabilities, even within the same probiotic species, is key to hy’s mission to become a leader in microbiome science. Explore the current research on Strain Number HY8002.
Patents
Research Papers on Strain HY8002

[SCIE] A Study on Barrier Protection and Immune Defense System Enhancement by B. lactis  HY8002

Probiotics are not only beneficial for gut health but may also be effective in strengthening the physical integrity of the intestinal wall and activating immune cells to boost the body's defense system.

 

In this study, we analyzed the viability of B. lactis HY8002 in the gastrointestinal tract and its effects on Peyer's patch cells and intestinal barrier reinforcement.

 

The results demonstrated the following functional properties of HY8002:

  • Strong survival and adhesion ability: Demonstrated the highest survival rate among Bifidobacterium strains in the gastrointestinal environment and excellent adhesion to intestinal epithelial cells
  • Promotion of immune factor (IgA) production: Significantly increased the secretion of immunoglobulin A (IgA), which acts as the first line of defense in the gut, in both cell and animal models
  • Recovery from antibiotic-induced damage: Restored the number of Peyer's cells and serum and fecal IgA levels that were reduced by antibiotic (kanamycin) treatment
  • Strengthening of tight junctions: Increased the expression of proteins and genes (e.g., ZO-1) that maintain intestinal barrier integrity, preventing barrier loosening
  • TLR2-mediated mechanism: Scientifically demonstrated that barrier reinforcement and immune enhancement effects are mediated through TLR2 receptors
  • Microbiome restoration and safety: Restored the gut microbiota disrupted by antibiotics and confirmed the absence of toxic factors through genomic analysis

 

Analysis based on animal and cell experiments demonstrated that HY8002 is a potent functional probiotic that activates the intestinal immune system and strengthens physical barriers to protect the body from harmful external factors.

The information provided is general academic and patent-related content concerning the raw material and does not describe the efficacy or effects of any specific product.
Research Papers on Strain HY8002

[SCIE] A Study on the Protective Effects of HY2782 and HY8002 on PM2.5-induced Lung Inflammation

Probiotics are not only beneficial for gut health but may also be effective in alleviating lung inflammation caused by the inhalation of fine dust and boosting respiratory defenses

 

This study examined the changes in lung inflammation markers and antioxidant responses when L. casei HY2782 and B. lactis HY8002 were orally administered to a mouse model chronically exposed to particulate matter (PM2.5).

 

The results demonstrated the following functional properties of HY2782 and HY8002:

  • Inhibition of inflammatory cell infiltration: Effectively prevented the infiltration of eosinophils and neutrophils that exacerbate inflammation in bronchoalveolar lavage fluid (BALF)
  • Inhibition of leukocyte activation and inflammatory cytokines: Reduced the migration of leukocytes activated by fine dust and alleviated the production of inflammation-inducing substances
  • Increased antioxidant enzyme activity: Reduced oxidative stress by increasing the activity of the antioxidant enzymes superoxide dismutase (SOD) and catalase in the blood
  • Removal of reactive oxygen species (ROS): Effectively eliminated ROS induced by fine dust to protect cells from damage
  • Confirmation of respiratory protection mechanism: Suppressed lung inflammatory responses through multiple pathways, thereby protecting respiratory health

 

Analysis using animal models demonstrated that HY2782 and HY8002 probiotics can act as powerful protective agents against lung damage and inflammation caused by fine dust exposure.

The information provided is general academic and patent-related content concerning the raw material and does not describe the efficacy or effects of any specific product.
Research Papers on Strain HY8002

[SCIE] A Study on Immunity Enhancement and Improvement of Immunodeficiency by HY8002 and HY7717 Probiotic Complex

Probiotics are not only beneficial for gut health but may also help activate immune cells and restore compromised immune function caused by medications or other factors.

 

In this study, we analyzed the synergistic effects of the B. lactis  HY8002와 L. plantarum  HY7717 complex on immune markers in a mouse model with immunosuppression induced by cyclophosphamide (CTX).

 

The results demonstrated the following functional properties of the HY8002 and HY7717 complex:

  • Increase in immune-activating cytokines: Significantly promoted the secretion of interferon gamma (IFN-γ), interleukin-12 (IL-12), and tumor necrosis factor (TNF-α), which play key roles in immune responses, from splenocytes
  • Improvement in blood and immune indicators: Effectively restored spleen indices and hematological values that had decreased due to immunosuppressants
  • Activation of NK cells and immunoglobulins: Increased the activity of natural killer (NK) cells that target foreign invaders and increased plasma immunoglobulin levels, thereby strengthening the immune system
  • Immunomodulation via the TLR2 pathway: Scientifically demonstrated that these immune-enhancing effects are closely associated with the activation of the immune signaling receptor TLR2
  • Potential for various applications: Demonstrated high value as a functional probiotic material for boosting the immune system when applied to dairy products such as yogurt and cheese

 

Analysis based on animal and cell experiments demonstrated that the HY8002 and HY7717 complex can serve as an effective immune support dietary supplement by potently stimulating and restoring the body's immune response even in immunosuppressive conditions, thereby helping to protect overall health.

The information provided is general academic and patent-related content concerning the raw material and does not describe the efficacy or effects of any specific product.
Patents Associated with Strain HY8002
Patent Registration No. 10-1932955

Probiotic composition for improving intestinal flora

This is a composition that combines HY8002 with Lactobacillus plantarum HY7712 and Lactobacillus casei HY2782 to restore the disrupted intestinal flora of cancer patients or post-operative patients.

The information provided is general academic and patent-related content concerning the raw material and does not describe the efficacy or effects of any specific product.
Patents Associated with Strain HY8002
Patent Registration No. 10-2310175

Composition for improving colon function including a mixture of probiotics and natural substances

This is a composition that contains a mixture of probiotics including HY8002, HY7712, and HY2782 and natural ingredients such as lactulose, burdock, and digestion-resistant maltodextrin to improve colon function.

The information provided is general academic and patent-related content concerning the raw material and does not describe the efficacy or effects of any specific product.
Patents Associated with Strain HY8002
Patent Registration No. 10-2763713

Probiotic coating method using selenium

HY8002 is included in the list of target strains to which selenium-based probiotic coating technology can be applied.

The information provided is general academic and patent-related content concerning the raw material and does not describe the efficacy or effects of any specific product.
Patents Associated with Strain HY8002
Patent Registration No. 10-2292475

Food composition for relieving nicotine withdrawal symptoms containing Bifidobacterium animalis subspecies lactis HY8002 as an active ingredient

It alleviates nicotine withdrawal symptoms by reducing the expression of nicotinic acetylcholine receptors (acr-15 and acr-19) in a Caenorhabditis elegans model.

The information provided is general academic and patent-related content concerning the raw material and does not describe the efficacy or effects of any specific product.
Patents Associated with Strain HY8002
Patent Registration No. 10-1958686

Composition for preventing and alleviating skin damage caused by fine dust containing Bifidobacterium animalis subspecies lactis HY8002 as an active ingredient

HY8002 reduces the expression of aryl hydrocarbon receptor (AhR), CYP1A1, and CYP1B1, which increase in human skin cells exposed to fine dust. This has the effect of protecting against skin cell death induced by fine dust and prevent skin damage.

The information provided is general academic and patent-related content concerning the raw material and does not describe the efficacy or effects of any specific product.
Patents Associated with Strain HY8002
Patent Registration No. 10-2404656

Composition for the prevention, improvement, or treatment of cognitive impairment and depression containing the Bifidobacterium animalis subspecies lactis HY8002 strain

HY8002 suppresses neuronal cell death caused by stress hormones (cortisol) and oxidative stress. Specifically, it increases the expression of brain-derived neurotrophic factor (BDNF) and the cell survival factor (RELA) while decreasing the expression of the apoptotic marker caspase-3, which suggests its potential utility in the prevention and treatment of cognitive impairments, including dementia and Alzheimer’s disease, as well as depression.

The information provided is general academic and patent-related content concerning the raw material and does not describe the efficacy or effects of any specific product.
Patents Associated with Strain HY8002
Patent Registration No. 10-2146706

Fermented red ginseng concentrate for improving allergic rhinitis, fortified with Bifidobacterium animalis subspecies lactis HY8002 and Bifidobacterium adolesentis HY8502 ginsenoside Rd

Red ginseng concentrate enriched with ginsenoside Rd through mixed fermentation with HY8002 and HY8502 strains has been shown to help improve allergic rhinitis by inhibiting the production of IL-4, IL-5, and IgE and by regulating gut microbiota balance.

The information provided is general academic and patent-related content concerning the raw material and does not describe the efficacy or effects of any specific product.
Patents Associated with Strain HY8002
Patent Registration No. 10-1971186

Method for manufacturing fermented red ginseng concentrate fortified with ginsenoside Rd using Bifidobacterium animalis subspecies lactis HY8002 and Bifidobacterium adolecentis HY8502

This technology relates to a manufacturing method for increasing the ginsenoside Rd content by fermenting red ginseng concentrate with a mixture of HY8002 and HY8502 strains in a 1:2 ratio.

The information provided is general academic and patent-related content concerning the raw material and does not describe the efficacy or effects of any specific product.
Patents Associated with Strain HY8002
Patent Registration No. 10-1965582

Fermented red ginseng concentrate with improved absorption and blood concentration maintenance time of active ingredients of red ginseng using probiotic fermentation, and products containing fermented red ginseng concentrate as an active ingredient

This technology relates to a fermented red ginseng concentrate in which red ginseng extract is subjected to triple ethanol extraction and subsequently fermented with HY8002 and HY8502 strains, thereby increasing the absorption of active ingredients and improving the blood concentration maintenance time.

The information provided is general academic and patent-related content concerning the raw material and does not describe the efficacy or effects of any specific product.
Patents Associated with Strain HY8002
Patent Registration No. 10-2408500

Food composition for alleviating nicotine toxicity and promoting decomposition containing a complex of HY8002 strain and hot water extract of Platycladus orientalis as an active ingredient

When used in combination with Platycladus orientalis leaf extract, it increases the enzyme (CYP2A6) that converts nicotine to cotinine and decreases the apoptosis factor (caspase-3), thereby alleviating nicotine toxicity and promoting breakdown

The information provided is general academic and patent-related content concerning the raw material and does not describe the efficacy or effects of any specific product.
Patents Associated with Strain HY8002
Patent Registration No. 10-2292475

Food composition for relieving nicotine withdrawal symptoms containing Bifidobacterium animalis subspecies lactis HY8002 as an active ingredient

It alleviates nicotine withdrawal symptoms by reducing the expression of nicotinic acetylcholine receptors (acr-15 and acr-19) in a Caenorhabditis elegans model.

The information provided is general academic and patent-related content concerning the raw material and does not describe the efficacy or effects of any specific product.